Table 3.

Patient outcome scores over time.

Follow-up	1 month	3 months	6 months	12 months
No. of patients
Modified	97	93	89	84
Traditional	94	91	86	82
PVR change (ml)
Modified	−86.0 ± 57.1	−92.4 ± 55.0	−93.3 ± 49.6	−97.1 ± 58.5
Traditional	−102.0 ± 55.9	−107.9 ± 56.2	−108.6 ± 60.2	−111.4 ± 42.6
p value	0.052∗	0.060∗	0.068∗	0.074∗
IPSS score change
Modified	−13.8 ± 3.07	−15.8 ± 3.56	−16.3 ± 2.76	−16.6 ± 2.10
Traditional	−13.7 ± 3.41	−16.0 ± 3.29	−16.4 ± 2.51	−16.8 ± 2.83
p value	0.831∗	0.693∗	0.803∗	0.605∗
QoL score change
Modified	−2.2 ± 0.99	−3.1 ± 0.63	−3.2 ± 0.58	−3.4 ± 0.52
Traditional	−1.8 ± 0.76	−2.8 ± 0.77	−3.0 ± 0.60	−3.2 ± 0.53
p value	0.002∗	0.004∗	0.026∗	0.015∗
Q max change
Modified	+15.3 ± 2.43	+16.6 ± 2.88	+17.4 ± 3.19	+17.3 ± 3.28
Traditional	+16.7 ± 4.12	+17.4 ± 3.71	+18.4 ± 4.23	+18.1 ± 3.16
p value	0.005∗	0.428∗	0.079∗	0.163∗
IIFF score change
Modified			−1.3 ± 0.8	+0.8 ± 0.4
Traditional			−1.4 ± 0.9	+0.7 ± 0.4
p value			0.146∗	0.109∗

PVR = postvoid residual urine volume; IPSS = International Prostate Symptom Score; QoL = quality of life; Q_max = maximum flow rate; IIEF = International Index of Erectile Function; ^∗t-test.